Navin Fluorine International Limited — Investor Meet, 14-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** Navin Fluorine International reported consolidated sales of ₹606.2 Cr in Q3 FY25, up 21% Y-o-Y and 17% Q-o-Q. Operating EBITDA surged to ₹147.3 Cr, reflecting a remarkable 95% Y-o-Y increase, with an EBITDA margin of 24.3%, up 917 bps Y-o-Y and 360 bps Q-o-Q. Operating PBT showed significant growth at ₹97.5 Cr, marking a 195% Y-o-Y rise and 49% Q-o-Q improvement.

**Future Outlook and Growth Drivers:** Management highlighted strategic investments, including a ₹450 Cr capex for a new HF capacity at Dahej, scheduled for commissioning in early FY26, and an additional R32 capacity expansion for ₹84 Cr expected to be operational by February 2025. There is strong order visibility across its business verticals, particularly in specialty chemicals and CDMO segments.

**Order Book and Operational Updates:** Strong order book visibility was emphasized, with substantial capacity utilization and new contracts for FY26. Commercial production at the Dahej facility has commenced, showcasing positive operational momentum.

**Analyst Q&A Insights:** Analysts probed the sustainability of revenue growth, to which management reiterated positive demand trends and operational efficiencies as key profit drivers. Questions regarding competitive positioning revealed confidence in maintaining market share amid rising competition. Concerns about supply chain disruptions were acknowledged, with management indicating preparedness to mitigate potential risks. On capex, management justified current spending as essential for future growth.

**Strategic Focus Areas:** The call underscored a focus on innovation and sustainability. Management’s tone conveyed confidence in leveraging operational excellence to navigate challenges, while reinforcing the importance of strategic partnerships to drive growth.

**Investor Insight:** The robust financial metrics and clear growth trajectory suggest a favorable outlook. Given the company’s strategic initiatives and management's confidence, the observed fundamentals align more with a ‘buy’ stance, as risks appear manageable amidst a dynamic market environment.